...
首页> 外文期刊>The Journal of Bone and Joint Surgery. American Volume >Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein.
【24h】

Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein.

机译:使用血管化的骨膜瓣,可生物降解的基质和骨形态发生蛋白修复大鼠股骨的临界大小缺损。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of this study was to evaluate the osseous healing of a critical-sized femoral defect in a rat model with use of recombinant human bone morphogenetic protein-2 (rhBMP-2), a matrix fabricated of D,D-L,L-polylactic and hyaluronan acid (OPLA-HY), and a vascularized periosteal flap. METHODS: The carrier matrix OPLA-HY with or without rhBMP-2 was implanted in a 1-cm-long femoral defect and secured with a plate and screws. In some groups, a vascularized periosteal flap was harvested from the medial surface of the tibia. In group 1, the femoral defects in the animals were filled with the OPLA-HY matrix alone; in group 2, the OPLA-HY matrix was covered by the vascularized periosteal flap; in group 3, 20 mug of rhBMP-2 was added to the OPLA-HY matrix; and in group 4, the femoral defect containing the OPLA-HY matrix and 20 mug of rhBMP-2 was wrapped circumferentially by the vascularized periosteal flap. The presence and density of new bone formation in the femoral defect were evaluated radiographically, histologically, and with histomorphometry at four and eight weeks postoperatively. RESULTS: Groups 1 and 2, which were not treated with rhBMP-2, showed no radiographic or histologic evidence of mature bone formation at four or eight weeks. Both groups 3 and 4, which were treated with rhBMP-2, demonstrated excellent bone formation. However, with the periosteal flap, group 4 demonstrated more bone formation on histomorphometric analysis at eight weeks (43.1%) than did group 3 (28.3%) (p < 0.01). Additionally, heterotopic bone formed outside the boundaries of the defect in eight of the fifteen animals in group 3, which had no periosteal flap. CONCLUSIONS: Bone-tissue engineering with use of the OPLA-HY matrix and rhBMP-2 produced good bone formation in the rat femoral defect model. However, the addition of a vascularized periosteal flap significantly increased bone formation within the boundaries of the defect and prevented heterotopic ossification.
机译:背景:本研究的目的是使用重组人骨形态发生蛋白2(rhBMP-2)(一种由D,DL,L-L制成的基质)评估大鼠模型中关键尺寸的股骨缺损的骨愈合情况。聚乳酸和透明质酸(OPLA-HY),以及血管化的骨膜瓣。方法:将带有或不带有rhBMP-2的载体基质OPLA-HY植入1cm长的股骨缺损中,并用钢板和螺钉固定。在某些组中,从胫骨内侧表面收获血管化的骨膜瓣。在第1组中,仅用OPLA-HY基质填充动物的股骨缺损。在第2组中,OPLA-HY基质被血管化的骨膜瓣覆盖。在第3组中,向OPLA-HY基质中加入20杯rhBMP-2。在第4组中,包含OPLA-HY基质和20杯rhBMP-2的股骨缺损被血管化的骨膜瓣沿周向包裹。术后四周和八周通过影像学,组织学和组织形态学评估股骨缺损中新骨形成的存在和密度。结果:未进行rhBMP-2治疗的第1组和第2组在第4或8周未显示任何放射学或组织学证据显示成熟的骨形成。用rhBMP-2处理的第3组和第4组均显示出极好的骨形成。然而,对于骨膜瓣,第4组在8周时的组织形态计量学分析显示出更多的骨形成(43.1%),比第3组(28.3%)多(p <0.01)。另外,在第3组的15只动物中的8只动物的缺损边界之外形成了异位骨,其没有骨膜瓣。结论:在大鼠股骨缺损模型中,使用OPLA-HY基质和rhBMP-2进行骨组织工程可产生良好的骨形成。但是,增加血管化的骨膜瓣可显着增加缺损边界内的骨形成并防止异位骨化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号